Educational visit

Anxiety: rethinking the options

Focuses on assessment of anxiety disorders and evidence-based approaches to management. Both psychological and pharmacological treatment options will be discussed

  • Start: 1 March 2019
  • Cost: free

BOOK NOW
Newtons cradle anxiety image
 

CPD Points

One-on-one discussion
This activity has been accredited for 2 (Category 2) points in the RACGP QI&CPD Program for the 2017–2019 triennium (activity number 142121) and for Mental Health CPD.

Small group meeting
This activity has been accredited for 2 (Category 2) points in the RACGP QI&CPD Program for the 2017–2019 triennium (activity number 143599) and for Mental Health CPD.

One-on-one discussion
This activity has been approved for 1 Core point in the ACRRM PD Program for the 2017 - 2019 triennium (activity code 14322).

Small group meeting
This activity has been approved for 1 Core point in the ACRRM PD Program for the 2017 - 2019 triennium (activity code 14374).

PIP QPI

 

About

Anxiety is the most common mental health problem reported in Australia.

Only 27% of people with anxiety disorders seek professional help, and of these 61% receive an evidence-based treatment. Improved awareness and education about anxiety can help both GPs and their patients recognise and manage anxiety disorders.  

Educational visits are available as a:

  • One-on-one discussion: a 30-minute in-practice discussion for GPs, tailored to individual learning needs. We also offer virtual visits via video conferencing software so that GPs who find it difficult to schedule an in-practice visit can still benefit from our visiting program.
  • Small-group: a 1-hour in-practice meeting for up to 10 health professionals (GPs, pharmacists and nurses).
 

Learning outcomes

Educational visits

On completion of this activity you should be able to:

  • differentiate between anxiety symptoms and anxiety disorder, by assessing severity, persistence, contributing factors and impact on the patient
  • discuss the impact of anxiety and provide psychoeducation to patients with anxiety
  • use evidence-based psychological therapies as first line for patients with mild to moderate anxiety
  • recognise SSRI antidepressant monotherapy as first line for patients with anxiety requiring pharmacological therapy
  • identify and address mental health polypharmacy in line with prescribing guidelines when starting and reviewing pharmacological therapy for anxiety.

Small group meeting

On completion of this activity you should be able to:

  • differentiate between anxiety symptoms and anxiety disorder, by assessing severity, persistence, contributing factors and impact on the patient
  • use evidence-based psychological treatments as first line for patients with mild or moderate anxiety
  • recognise SSRI antidepressant monotherapy as first line for patients with anxiety requiring pharmacological treatment
  • review the use of polypharmacy for anxiety, recognising the specific but limited role of antipsychotics and benzodiazepines
  • discuss systems in your practice and prioritise areas for improvement in the management of patients with anxiety.